Comparison of computerized prescribing assistance systems in COVID-19 patients: INTERCheck and Drug-PIN

This article was originally published here

SN Compr Clin Med. 2021; 4 (1): 3. doi: 10.1007 / s42399-021-01079-9. Online publication of December 27, 2021.


Infection with coronavirus disease 19 (COVID-19) requires significant efforts in health systems, due to the high risk of mortality, especially in subjects with significant comorbidity (≥ 2 pathologies) and polypharmacy ( ≥ 5 drugs). Treatment of COVID-19 requires careful evaluation, in order to reduce the risk of potentially unwanted drug reactions. The aim of the study was to examine the use of a computerized prescription medium in the management and treatment of COVID-19 infection. We evaluated n.33 patients (51% of women) admitted to the COVID West of low-medium intensity of care of the Sant’Andrea hospital during the period March-April 2020 and n.42 subjects (50% of women) admitted to the internal medicine department. (as a control group), by INTERCheck® and Drug-PIN®. Co-morbidity (n. Pathologies), polypharmacy (n. Drugs) and total INTERCheck score in COVID-19 patients and controls were, respectively (mean ± standard deviation): 5.8 ± 3.8, 7.9 ± 4.5 and 9.2 ± 7.1 and 6.8 ± 2.6, 8.0 ± 2.6 and 4.9 ± 3.8 (statistically significant for comorbidity p p p p

PMID: 34977463 | PMC: PMC8710931 | DOI: 10.1007 / s42399-021-01079-9

Source link

About Alex S. Crone

Check Also

Top 20 most expensive prescription drugs in 2022

If you thought inflation was high, wait until you hear about rising specialty drug prices. …